XP-XP Tibial Tray - Interlok 63 mm Item # 195751
FDA Device Recall #Z-2526-2019 — Class II — August 15, 2019
Recall Summary
| Recall Number | Z-2526-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 15, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Zimmer Biomet, Inc. |
| Location | Warsaw, IN |
| Product Type | Devices |
| Quantity | 480 units |
Product Description
XP-XP Tibial Tray - Interlok 63 mm Item # 195751
Reason for Recall
The locking bar not fully engaging
Distribution Pattern
State NY IN OH MI GA SC FL MO WI MN ND SD NE NJ PA MD IL IA CA VA NC DC WV AR AL MS AL MI WA OR ID LA FL KS TN MA KY OK TX TX CT AZ NV NM MT WY CO UT DC WY Country: KOREA CHINA CANADA AUSTRALIA JAPAN EMEA SWEDEN ITALY
Lot / Code Information
Lot Number 522520 571140 589700 758150 028960 028980 043970 028980R 043970R 064960 028970 065200 101860 101880 065200R 433940 321620 321640 321620R 321640R 433910 592120 592140 592150 592170 257970 592180 801960 282710 282710R 282690 801940 801950 783060 783040 011410 975550 592110 984660 023340 257960 840190 061310 592160 102990 223050 261130 336080 585400 585370 511430 467140 684820 664140 634080 705510 715730 716030 716030R 920550 881940 029210 906640 985880 072790 125870 162880 396240 318430 247250 336660 441870 374320 587220 509590 543180 543150 708390 576080 639600 670510 522580 558990 593560 450400 741460 758480 780160 808130 833150 873470 943480 850880 917590 183370 560280 570170 570180 570180R 076640 191080 111620 950910 963430 999270 018060 261910 613310 650370
Other Recalls from Zimmer Biomet, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0696-2021 | Class II | Spinal Rod Cutter, Item number 00392500200. The... | Nov 20, 2020 |
| Z-0570-2021 | Class II | Polaris 5.5 Spinal System and Polaris 5.5/Cyphe... | Nov 17, 2020 |
| Z-0372-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
| Z-0345-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
| Z-0347-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.